Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis
Authors
Keywords
Interleukin-35, Different subsets of CD4+ T cells, Interleukin-4, Systemic sclerosis
Journal
RHEUMATOLOGY INTERNATIONAL
Volume 38, Issue 8, Pages 1511-1519
Publisher
Springer Nature
Online
2018-05-30
DOI
10.1007/s00296-018-4071-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathogenesis of systemic sclerosis—current concept and emerging treatments
- (2017) Masutaka Furue et al. IMMUNOLOGIC RESEARCH
- Systemic sclerosis
- (2017) Christopher P Denton et al. LANCET
- Assessment of skin involvement in systemic sclerosis
- (2017) Gábor Kumánovics et al. RHEUMATOLOGY
- Points to consider—Raynaud’s phenomenon in systemic sclerosis
- (2017) Maurizio Cutolo et al. RHEUMATOLOGY
- Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis
- (2017) Dan Hu et al. Nature Communications
- Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases
- (2016) Shi-Yang Guan et al. INFLAMMATION
- Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement
- (2015) Andréa Tavares Dantas et al. CLINICAL RHEUMATOLOGY
- Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
- (2015) Katherine G. MacDonald et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- EBI3 Downregulation Contributes to Type I Collagen Overexpression in Scleroderma Skin
- (2015) Hideo Kudo et al. JOURNAL OF IMMUNOLOGY
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- (2013) Frank van den Hoogen et al. ARTHRITIS AND RHEUMATISM
- Assessment of T Regulatory Cells and Expanded Profiling of Autoantibodies May Offer Novel Biomarkers for the Clinical Management of Systemic Sclerosis and Undifferentiated Connective Tissue Disease
- (2013) Paola Cordiali-Fei et al. Clinical & Developmental Immunology
- A pro-fibrotic role for interleukin-4 in cardiac pressure overload
- (2012) P. Kanellakis et al. CARDIOVASCULAR RESEARCH
- Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis
- (2011) Daniela Fenoglio et al. CLINICAL IMMUNOLOGY
- Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study
- (2011) Tatiana S. Rodríguez-Reyna et al. RHEUMATOLOGY INTERNATIONAL
- Cytokine mRNA Profile of Alveolar T Lymphocytes and Macrophages in Patients with Systemic Sclerosis Suggests a Local Tr1 Response
- (2011) G. N. Andersen et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- IL-35-mediated induction of a potent regulatory T cell population
- (2010) Lauren W Collison et al. NATURE IMMUNOLOGY
- Les cytokines dans la sclérodermie systémique
- (2010) J. Baraut et al. PATHOLOGIE BIOLOGIE
- High-Resolution CT Scan Findings in Patients With Symptomatic Scleroderma-Related Interstitial Lung Disease
- (2008) Jonathan G. Goldin et al. CHEST
- Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
- (2007) Hélène Chifflot et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started